Answers are grounded in this paper and cite their sources.
Bone marrow transplantation protocols for inherited metabolic storage diseases are unique for each disorder treated. Differences depend also upon how old the patient was when onset occurred and rate of progression of disease. Treatment is directed to prevent or ameliorate the inexorable neurological deterioration that is the major pathophysiological event in all of these inherited metabolic storage diseases.
No takes yet. Share an insight, caveat, or question.
Krivit et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: